| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |